Share on StockTwits

Skyline Medical (NASDAQ:SKLN) major shareholder Samuel Herschkowitz bought 2,000 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were purchased at an average price of $0.12 per share, for a total transaction of $240.00. Following the completion of the acquisition, the insider now directly owns 46,782,377 shares of the company’s stock, valued at approximately $5,613,885. The acquisition was disclosed in a filing with the SEC, which is available at this link. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Skyline Medical (NASDAQ:SKLN) opened at 0.1445 on Friday. Skyline Medical has a 52-week low of $0.106 and a 52-week high of $0.47. The stock has a 50-day moving average of $0.13 and a 200-day moving average of $0.17. The company’s market cap is $32.2 million.

Skyline Medical Inc, formerly BioDrain Medical, Inc, is an early stage medical device company. The Company owns patent rights to its products and will distribute its products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed.

Receive News & Ratings for Skyline Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skyline Medical Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.